Buccal Midazolam Spray as an Alternative to Intranasal Route for Conscious Sedation in Pediatric Dentistry

Objectives: To evaluate the acceptance of midazolam spray through buccal route as compared to intranasal route and compare the efficacy of the drug through both the routes. Study Design: 30 patients aged 2-8 years with Grade I or II Frankl's Behaviour Rating Scale were selected who required similar treatment under local anesthesia on two teeth. Midazolam spray was administered randomly through buccal or intranasal routes for the two appointments. Scoring was done for the acceptance of drug and Houpt's score was recorded for the behaviour of patients during the treatment. Results: Acceptance of drug through buccal route was significantly better than the intranasal route (p<0.05) but no statistically significant difference was found in the behaviour scores for the two routes of administration (p≯0.05). Conclusion: Midazolam spray can be effectively used through the buccal mucosa in children who give poor compliance with the intranasal administration.

Buccal midazolam, Conscious sedation, Pediatric dentistry

1. Wilson KE, Welbury RR, Girdler NM. A study of the effectiveness of oral midazolam sedation for orthodontic extraction of permanent teeth in children: a prospective, randomised, controlled, crossover trial. Br Dent J, 192: 457-62, 2002.

2. Primosch RE, Guelmann M. Comparison of drops versus spray administration of intranasal midazolam in two and three-year-old children for dental sedation. Pediatr Dent, 27(5): 401-8, 2005.

3. Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious sedation of children. Pediatr Dent, 15(4): 237-241, 1993.

4. Wilson KE, Welbury RR, Girdler NM. Comparison of transmucosal midazolam with inhalation sedation for dental extractions in children. A randomized, cross-over, clinical trial. Acta Anaesthesiol Scand, 51: 1062–1067, 2007.

5. al-Rakaf H, Bello LL, Turkustani A, Adenubi JO. Intra-nasal midazolam in conscious sedation of young paediatric dental patients. Int J Paediatr Dent, 11(1): 33-40, 2001.

6. Mazaheri R, Eshghi A, Bashardoost N, Kavyani N. Assessment of intranasal midazolam administration with a dose of 0.5 mg/ Kg in behavior management of uncooperative children. J Clin Pediatr Dent, 32(2): 95–100, 2007.

7. Lane RD, Schunk JE. Atomized intranasal midazolam use for minor procedures in the pediatric emergency department. Pediatric Emergency Care, 24(5): 300-303, 2008.

8. Dallman JA, Ignelzi Jr. MA, Briskie DM. Comparing the safety, efficacy and recovery of intranasal midazolam vs. oral chloral hydrate and promethazine. Pediatr Dent, 23(5): 424-30, 2001.

9. Griffith N, Howel S, Mason DG. Intranasal midazolam for premedication of children undergoing day-case anesthesia: comparison of two delivery systems with assessment of intra-observer variability. Br J Anaes, 81: 865-69, 1998.

10. Geldner G, Hubmann M, Knoll R, Jacobi K. Comparison between three transmucosal routes of administration of midazolam in children. Pediatr Anesth, 7(2): 103-109, 1997.

11. Ljungman G, Kreuger A, Andreasson S, Gordh T, Sorensen S. Midazolam nasal spray reduces procedural anxiety in children. Pediatrics, 105(1): 73-78, 2000.

12. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients- comparison of the nasal and sublingual routes. Anesthesiology, 78(5):885-91, 1993.

13. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci, 1(1):15-30,1998.

14. Haas DA, Nenniger SA, Yacobi R, Magathan JG, Grad HA, Copp PE, Charendoff MD. A Pilot Study of the Efficacy of Oral Midazolam for Sedation in Pediatric Dental Patients. Anesth Prog, 43:1-8, 1996.

15. Houpt MI, Kupietzky A, Tofsky NS, Koenigsberg SR. Effects of nitrous oxide on diazepam sedation of young children. Pediatr Dent, 18(3):236-41, 1996.

16. Schwagmeier R, Alincic S, Striebel HW. Midazolam pharmacokinetics 46(3): 203-206, 1998.

17. Klein EJ, Brown JC, Kobayashi A, Osincup D, Seidel K. A randomized clinical trial comparing oral, aerosolized intranasal, and aerosolized buccal midazolam. Ann Emerg Med. 2011 Jun 18. [Epub ahead of print]